Cargando…
Capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care COVID-19 testing
As the SARS-CoV-2 pandemic continues to spread, the necessity for rapid, easy diagnostic capabilities could never have been more crucial. With this aim in mind, we have developed a cost-effective and time-saving testing methodology/strategy that implements a sensitive reverse transcriptase loop-medi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406210/ https://www.ncbi.nlm.nih.gov/pubmed/34711332 http://dx.doi.org/10.1016/j.aca.2021.339002 |
_version_ | 1783746476965363712 |
---|---|
author | John, Anto J.U.K. He, Peijun J.W. Katis, Ioannis N. Galanis, P.P. Iles, Alice H. Eason, Robert W. Sones, Collin L. |
author_facet | John, Anto J.U.K. He, Peijun J.W. Katis, Ioannis N. Galanis, P.P. Iles, Alice H. Eason, Robert W. Sones, Collin L. |
author_sort | John, Anto J.U.K. |
collection | PubMed |
description | As the SARS-CoV-2 pandemic continues to spread, the necessity for rapid, easy diagnostic capabilities could never have been more crucial. With this aim in mind, we have developed a cost-effective and time-saving testing methodology/strategy that implements a sensitive reverse transcriptase loop-mediated amplification (RT-LAMP) assay within narrow, commercially available and cheap, glass capillaries for detection of the SARS-CoV-2 viral RNA. The methodology is compatible with widely used laboratory-based molecular testing protocols and currently available infrastructure. It employs a simple rapid extraction protocol that lyses the virus, releasing sufficient genetic material for amplification. This extracted viral RNA is then amplified using a SARS-CoV-2 RT-LAMP kit, at a constant temperature and the resulting amplified product produces a colour change which can be visually interpreted. This testing protocol, in conjunction with the RT-LAMP assay, has a sensitivity of ∼100 viral copies per reaction of a sample and provides results in a little over 30 min. As the assay is carried out in a water bath, commonly available within most testing laboratories, it eliminates the need for specialised instruments and associated skills. In addition, our testing pathway requires a significantly reduced quantity of reagents per test while providing comparable sensitivity and specificity to the RT-LAMP kit used in this study. While the conventional technique requires 25 μl of reagent, our test only utilises less than half the quantity (10 μl). Thus, with its minimalistic approach, this capillary-based assay could be a promising alternative to the conventional testing, owing to the fact that it can be performed in resource-limited settings, using readily available apparatus, and has the potential of increasing the overall testing capacity, while also reducing the burden on supply chains for mass testing. |
format | Online Article Text |
id | pubmed-8406210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84062102021-08-31 Capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care COVID-19 testing John, Anto J.U.K. He, Peijun J.W. Katis, Ioannis N. Galanis, P.P. Iles, Alice H. Eason, Robert W. Sones, Collin L. Anal Chim Acta Article As the SARS-CoV-2 pandemic continues to spread, the necessity for rapid, easy diagnostic capabilities could never have been more crucial. With this aim in mind, we have developed a cost-effective and time-saving testing methodology/strategy that implements a sensitive reverse transcriptase loop-mediated amplification (RT-LAMP) assay within narrow, commercially available and cheap, glass capillaries for detection of the SARS-CoV-2 viral RNA. The methodology is compatible with widely used laboratory-based molecular testing protocols and currently available infrastructure. It employs a simple rapid extraction protocol that lyses the virus, releasing sufficient genetic material for amplification. This extracted viral RNA is then amplified using a SARS-CoV-2 RT-LAMP kit, at a constant temperature and the resulting amplified product produces a colour change which can be visually interpreted. This testing protocol, in conjunction with the RT-LAMP assay, has a sensitivity of ∼100 viral copies per reaction of a sample and provides results in a little over 30 min. As the assay is carried out in a water bath, commonly available within most testing laboratories, it eliminates the need for specialised instruments and associated skills. In addition, our testing pathway requires a significantly reduced quantity of reagents per test while providing comparable sensitivity and specificity to the RT-LAMP kit used in this study. While the conventional technique requires 25 μl of reagent, our test only utilises less than half the quantity (10 μl). Thus, with its minimalistic approach, this capillary-based assay could be a promising alternative to the conventional testing, owing to the fact that it can be performed in resource-limited settings, using readily available apparatus, and has the potential of increasing the overall testing capacity, while also reducing the burden on supply chains for mass testing. Elsevier B.V. 2021-11-15 2021-08-31 /pmc/articles/PMC8406210/ /pubmed/34711332 http://dx.doi.org/10.1016/j.aca.2021.339002 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article John, Anto J.U.K. He, Peijun J.W. Katis, Ioannis N. Galanis, P.P. Iles, Alice H. Eason, Robert W. Sones, Collin L. Capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care COVID-19 testing |
title | Capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care COVID-19 testing |
title_full | Capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care COVID-19 testing |
title_fullStr | Capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care COVID-19 testing |
title_full_unstemmed | Capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care COVID-19 testing |
title_short | Capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care COVID-19 testing |
title_sort | capillary-based reverse transcriptase loop-mediated isothermal amplification for cost-effective and rapid point-of-care covid-19 testing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406210/ https://www.ncbi.nlm.nih.gov/pubmed/34711332 http://dx.doi.org/10.1016/j.aca.2021.339002 |
work_keys_str_mv | AT johnantojuk capillarybasedreversetranscriptaseloopmediatedisothermalamplificationforcosteffectiveandrapidpointofcarecovid19testing AT hepeijunjw capillarybasedreversetranscriptaseloopmediatedisothermalamplificationforcosteffectiveandrapidpointofcarecovid19testing AT katisioannisn capillarybasedreversetranscriptaseloopmediatedisothermalamplificationforcosteffectiveandrapidpointofcarecovid19testing AT galanispp capillarybasedreversetranscriptaseloopmediatedisothermalamplificationforcosteffectiveandrapidpointofcarecovid19testing AT ilesaliceh capillarybasedreversetranscriptaseloopmediatedisothermalamplificationforcosteffectiveandrapidpointofcarecovid19testing AT easonrobertw capillarybasedreversetranscriptaseloopmediatedisothermalamplificationforcosteffectiveandrapidpointofcarecovid19testing AT sonescollinl capillarybasedreversetranscriptaseloopmediatedisothermalamplificationforcosteffectiveandrapidpointofcarecovid19testing |